mirikizumab – Talk Bio

Actionable Insights Powered by AI

Lilly’s Omvoh Outperforms J&J’s Stelara in Phase III Crohn’s Disease Trial

6 months ago talkbio0Tagged Crohn 's disease, Eli, Eli Lilly, Inflammatory Bowel Diseases, mirikizumab, Phase 3 Clinical Trials, Stelara, ustekinumab

Omvoh (mirikizumab), Stelara (ustekinumab), Crohn’s disease, Phase III trial, Inflammatory bowel disease (IBD), Eli Lilly, Johnson & Johnson

Mirikizumab Shows Superior Histologic Response in Crohn’s Disease Compared to Ustekinumab

6 months ago talkbio0Tagged Crohn 's disease, Histologic Response, Inflammatory Bowel Diseases, mirikizumab, ustekinumab, VIVID-1 trial

Mirikizumab, Ustekinumab, Crohn’s Disease, Histologic Response, VIVID-1 Trial, Inflammatory Bowel Disease